EU evaluates Roche arthritis drug as COVID-19 treatment – Reuters

EU evaluates Roche arthritis drug as COVID-19 treatment – Reuters

The European Union’s drugs regulator is evaluating the use of Roche’s (ROG.S) arthritis drug, Actemra, in hospitalised adult patients with severe COVID-19, it said on Monday.

Read More…

You May Also Like